These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 7307449

  • 21. L-dopa and carbidopa (sinemet) in the management of parkinsonism.
    Critchley E.
    Postgrad Med J; 1975 Sep; 51(599):619-21. PubMed ID: 1105500
    [Abstract] [Full Text] [Related]

  • 22. Acute vs chronic effects of l-dopa on bladder function in patients with mild Parkinson disease.
    Brusa L, Petta F, Pisani A, Moschella V, Iani C, Stanzione P, Miano R, Finazzi-Agrò E.
    Neurology; 2007 May 01; 68(18):1455-9. PubMed ID: 17470746
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Sinemet - 25/100.
    Med Lett Drugs Ther; 1980 Jun 13; 22(12):51. PubMed ID: 7374623
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Carbidopa dosage modifies L-dopa induced side effects and blood levels of L-dopa and other amino acids in advanced parkinsonism.
    Bermejo Pareja F, Martinez-Martin P, Muradas V, de Yébenes JG.
    Acta Neurol Scand; 1985 Nov 13; 72(5):506-11. PubMed ID: 4082917
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Anticholinergics and dyskinesia.
    Linazasoro G.
    Mov Disord; 1994 Nov 13; 9(6):689. PubMed ID: 7845412
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Enteral levodopa/carbidopa infusion in advanced Parkinson disease: long-term exposure.
    Nyholm D, Lewander T, Johansson A, Lewitt PA, Lundqvist C, Aquilonius SM.
    Clin Neuropharmacol; 2008 Nov 13; 31(2):63-73. PubMed ID: 18382177
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Initiating intrajejunal infusion of levodopa/carbidopa intestinal gel: an outpatient model.
    Fasano A, Liu LW, Poon YY, Lang AE.
    Mov Disord; 2015 Apr 13; 30(4):598-9. PubMed ID: 25771971
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.